KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Merck (MRK) Revenue (2016 - 2025)

Merck (MRK) has disclosed Revenue for 17 consecutive years, with $16.4 billion as the latest value for Q4 2025.

  • Quarterly Revenue rose 4.97% to $16.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $65.0 billion through Dec 2025, up 1.31% year-over-year, with the annual reading at $65.0 billion for FY2025, 1.31% up from the prior year.
  • Revenue for Q4 2025 was $16.4 billion at Merck, down from $17.3 billion in the prior quarter.
  • The five-year high for Revenue was $17.3 billion in Q3 2025, with the low at $10.6 billion in Q1 2021.
  • Average Revenue over 5 years is $14.9 billion, with a median of $15.3 billion recorded in 2023.
  • The sharpest move saw Revenue fell 11.86% in 2021, then surged 49.63% in 2022.
  • Over 5 years, Revenue stood at $13.5 billion in 2021, then increased by 2.29% to $13.8 billion in 2022, then rose by 5.78% to $14.6 billion in 2023, then increased by 6.79% to $15.6 billion in 2024, then rose by 4.97% to $16.4 billion in 2025.
  • According to Business Quant data, Revenue over the past three periods came in at $16.4 billion, $17.3 billion, and $15.8 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.